These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28544018)

  • 1. Next-Generation Nucleic Acid Aptamers with Two-Base-Modified Nucleotides Have Improved Binding Affinity and Potency.
    AlShamaileh H; Veedu RN
    Chembiochem; 2017 Aug; 18(16):1565-1567. PubMed ID: 28544018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of DNA aptamers with two modified bases.
    Gawande BN; Rohloff JC; Carter JD; von Carlowitz I; Zhang C; Schneider DJ; Janjic N
    Proc Natl Acad Sci U S A; 2017 Mar; 114(11):2898-2903. PubMed ID: 28265062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategies.
    Lipi F; Chen S; Chakravarthy M; Rakesh S; Veedu RN
    RNA Biol; 2016 Dec; 13(12):1232-1245. PubMed ID: 27715478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary electrophoresis-systematic evolution of ligands by exponential enrichment selection of base- and sugar-modified DNA aptamers: target binding dominated by 2'-O,4'-C-methylene-bridged/locked nucleic acid primer.
    Kasahara Y; Irisawa Y; Fujita H; Yahara A; Ozaki H; Obika S; Kuwahara M
    Anal Chem; 2013 May; 85(10):4961-7. PubMed ID: 23662585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Toolbox for Modified Aptamers.
    Lapa SA; Chudinov AV; Timofeev EN
    Mol Biotechnol; 2016 Feb; 58(2):79-92. PubMed ID: 26607475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of an aptamer for use as an affinity reagent with MS: PCSK9 as an example protein.
    Gupta V; Lassman ME; McAvoy T; Lee AY; Chappell DL; Laterza OF
    Bioanalysis; 2016 Aug; 8(15):1557-1564. PubMed ID: 27397798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2'-Deoxy purine, 2'-O-methyl pyrimidine (dRmY) aptamers as candidate therapeutics.
    Burmeister PE; Wang C; Killough JR; Lewis SD; Horwitz LR; Ferguson A; Thompson KM; Pendergrast PS; McCauley TG; Kurz M; Diener J; Cload ST; Wilson C; Keefe AD
    Oligonucleotides; 2006; 16(4):337-51. PubMed ID: 17155909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Screening and characterization of DNA aptamers with hTNF-alpha binding and neutralizing activity].
    Guo KT; Yan XR; Huang GJ; Xu CX; Chai YS; Zhang ZQ
    Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):730-3. PubMed ID: 15971588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemical biology of aptamers.
    Mayer G
    Angew Chem Int Ed Engl; 2009; 48(15):2672-89. PubMed ID: 19319884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of an LNA-modified ricin RNA aptamer.
    Förster C; Zydek M; Rothkegel M; Wu Z; Gallin C; Geßner R; Lisdat F; Fürste JP
    Biochem Biophys Res Commun; 2012 Mar; 419(1):60-5. PubMed ID: 22326915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SELEX Modifications and Bioanalytical Techniques for Aptamer-Target Binding Characterization.
    Tan SY; Acquah C; Sidhu A; Ongkudon CM; Yon LS; Danquah MK
    Crit Rev Anal Chem; 2016 Nov; 46(6):521-37. PubMed ID: 26980177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of high-affinity DNA aptamers using an expanded genetic alphabet.
    Kimoto M; Yamashige R; Matsunaga K; Yokoyama S; Hirao I
    Nat Biotechnol; 2013 May; 31(5):453-7. PubMed ID: 23563318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and characterization of enantioselective DNA aptamers for ibuprofen.
    Kim YS; Hyun CJ; Kim IA; Gu MB
    Bioorg Med Chem; 2010 May; 18(10):3467-73. PubMed ID: 20456958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of C-5 propynyl pyrimidine-containing oligonucleotides in vitro and in vivo.
    Shen L; Siwkowski A; Wancewicz EV; Lesnik E; Butler M; Witchell D; Vasquez G; Ross B; Acevedo O; Inamati G; Sasmor H; Manoharan M; Monia BP
    Antisense Nucleic Acid Drug Dev; 2003; 13(3):129-42. PubMed ID: 12954113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of base-modification on target binding of small molecule DNA aptamers.
    Imaizumi Y; Kasahara Y; Fujita H; Kitadume S; Ozaki H; Endoh T; Kuwahara M; Sugimoto N
    J Am Chem Soc; 2013 Jun; 135(25):9412-9. PubMed ID: 23734784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Searching the Sequence Space for Potent Aptamers Using SELEX in Silico.
    Zhou Q; Xia X; Luo Z; Liang H; Shakhnovich E
    J Chem Theory Comput; 2015 Dec; 11(12):5939-46. PubMed ID: 26642994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of RNA libraries for in vitro selection of aptamers.
    Chushak YG; Martin JA; Chávez JL; Kelley-Loughnane N; Stone MO
    Methods Mol Biol; 2014; 1111():1-15. PubMed ID: 24549608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?
    Dausse E; Da Rocha Gomes S; Toulmé JJ
    Curr Opin Pharmacol; 2009 Oct; 9(5):602-7. PubMed ID: 19717337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.
    Ni S; Yao H; Wang L; Lu J; Jiang F; Lu A; Zhang G
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.